Table 1.
Study Year | Year | Male | Age | Sample size | Follow up | PROM | Pre | Post |
---|---|---|---|---|---|---|---|---|
Larson and Giveans [6] | 2008 | 56% | 34.7 | 96 | 9.9 month | VAS | 6.74 | 1.88 |
Horisberger et al. [4] | 2010 | 73% | 40.9 | 105 | 2.3 years | VAS | 5.5 | 1.5 |
Larson and Giveans [10] | 2009 | 61% (debrid) | 32 | 44 | 44 months | VAS | 6.5 | 1.7 |
58% (refix) | 28 | 50 | 41 months | VAS | 5.7 | 0.7 | ||
Palmer et. al [5] | 2012 | 49% | 40.2 | 201 | 46 months | VAS | 6.8 | 2.7 |
Bardakos et al. [11]* | 2008 | 58% | 33 | 24 | 1 year | mHHS | 65 | 91 |
Byrd et al. [12] | 2009 | 69% | 33 | 200 | 16 months | mHHS | 65 | 85 |
Clohisy et al. [7] | 2010 | 80% | 34 | 35 | 2.2 year | mHHS | 63.8 | 85.9 |
Haviv et al. [13] | 2010 | 80% | 37 | 166 | 22 months | mHHS | 70.7 | 86.1 |
Byrd and Jones [9] | 2011 | 67% | 34 | 100 | 2 years | mHHS | 65 | 86.5 |
Byrd et al. [14] | 2011 | 74% | 28.6 | 116 | 19 Months | mHHS | 72 | 96 |
Philippon et al. [15] | 2009 | 45% | 40.6 | 112 | 2.3 years | mHHS | 58 | 84.3 |
HOS | 70 | 87.8 | ||||||
Nho et al. [2] | 2011 | 72% | 22.8 | 47 | 27 months | mHHS | 68.6 | 88.5 |
HOS | 78.8 | 91.4 |
*MHHS is multiplied with 1.1. This makes the scores comparable with the other studies [16].